Tenzing Acquisition
Why Robinhood?
You can watch TZAC and buy or sell other stocks, ETFs, and their options commission-free!About TZAC
Reviva Pharmaceuticals Holdings, Inc. is a clinical-stage biopharmaceutical company, which engages in the discovery and development of therapeutics for the central nervous system, respiratory, and metabolic diseases. It uses chemical genomics driven technology platform and proprietary chemistry to develop new medicines.
TZAC Key Statistics
Stock Snapshot
The current Tenzing Acquisition(TZAC) stock price is $2.88, with a market capitalization of 13.87M. The stock trades at a price-to-earnings (P/E) ratio of -0.27.
On 2026-03-14, Tenzing Acquisition(TZAC) shares started trading at —, with intraday highs of — and lows of —.
Trading volume for Tenzing Acquisition(TZAC) stock has reached 0, versus its average volume of 256.38K.
The stock's 52-week range extends from a low of $2.37 to a high of $23.40.
The stock's 52-week range extends from a low of $2.37 to a high of $23.40.
People also own
Similar Marketcap
This list is generated by looking at the six larger and six smaller companies by market cap in relation to this company.
Popular Stocks
This list is generated by looking at the top 100 stocks and ETFs most commonly held by Robinhood customers and showing a random subset
Newly Listed
This list is generated by showing companies that recently went public.